Yeqian Zhao

Little to no expression of angiotensin‐converting enzyme‐2 on most human peripheral blood immune cells but highly expressed on tissue macrophages

Xiang Song, Wei Hu, Haibo Yu et al. · Cytometry Part A · 2020 · 118 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients

Xiang Song, Wei Hu, Haibo Yu et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD

Yanmin Zhao, Yi Luo, Jimin Shi et al. · Blood · 2025 · 16 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study

Weihao Chen, Jingtao Huang, Yeqian Zhao et al. · Journal of Translational Medicine · 2024 · 14 citations · Full text

Medicine, Hematology, Molecular Medicine +17